Announcements Trials
Browse Landscape

Phase

Phase 2 76Phase 3 16Phase 1 7Phase 2/3 6Phase 1/2 5Phase NA 4Phase 4 3

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × nimotuzumab × Clear all
NCT06879691 2025-03-17

A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 4 Active not recruiting
171 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02945267 2016-10-26

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Chinese PLA General Hospital

Phase 4 Unknown
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02293356 2015-08-19

Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 4 Unknown
2,000 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡